Medical R&D convention derailed: implications for the global health system
Kiddell-Monroe, Rachel; Iversen, Johanne Helene; Gopinathan, Unni.
Journal of Health Diplomacy
; 1(1): [6], 2013.
Artículo
en Inglés
| LILACS, BDS | ID: biblio-832158
Potentially game-changing proposals to improve access to medicines have been stalled by the member states of the World Health Organization (WHO). In April 2012, the WHO Consultative Expert Working Group on Research and Development (CEWG) concluded that one way to address market failures in medical research and development (R&D) for diseases affecting the poorest populations was to negotiate a Medical R&D Convention1 (CEWG, 2012). This could lead to sustainable change within financing, monitoring and coordination of R&D rather than just trying to mend the existing system (Røttingen & Chamas, 2012). To the disappointment of some states and many civil society actors, a recent meeting of the WHO suspended the negotiations (Love, 2012). While some consider the global economic climate unable to support a convention that would require significant time and funding, we demonstrate that the current global health system has failed once more to address one of the most pressing global health challenges of our time. In this commentary, we show how thwarted attempts to develop an R&D convention have spurred our call for fresh debate on the viability of the very foundations of the current global health system.
Biblioteca responsable:
BR2260
Texto completo
Documentos relacionados